Kmart Pharmacy, a Sears Holdings Corp. company, said Tuesday that it has lowered the cost of Adrenaclick, a generic epinephrine auto-injector pen, to as low as $0 for insured patients and about $200 for patients paying cash for a two-pack. That compares to more than $642 for Mylan N.V.’s EpiPen, and $330 for Mylan’s generic version, Kmart said. Sears shares are down more than 5% in Tuesday trading, and 33% for the past year. The company’s shares are up 27.2% for the year to date while the S&P 500 index is up 6.6% for the period.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News